ArticleScientific reports2025
Molecularly imprinted electrochemical sensor based on copper 4-amino benzoic acid metal-organic framework for determination of pregabalin: electrochemical and DFT studies.
Article in Scientific reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
This study introduces a novel detection approach for determining trace levels of pregabalin (PGB), which utilizes the combination of two advanced metal-organic frameworks (MOFs) with a molecularly imprinted polymer (MIP) technique. For this purpose, we have developed a highly sensitive electrochemical sensor for measuring and determining PGB. The first step involved modifying a carbon paste electrode (CPE) with a Cu-MOF. PGB was employed as a template in the electropolymerization of poly-orthophenylenediamine (POPD) by cyclic voltammetry. The sensors' electrochemical performance was evaluated using cyclic voltammetry (CV), differential pulse voltammetry (DPV), and electrochemical impedance spectroscopy (EIS). The results obtained from the DPV revealed three linear response ranges of 0.003-0.09 µM,0.1-1 µM, and 1-90 µM with a low detection limit of 1.2 nM (signal-to-noise ratio = 3) and sensitivity 17.20 µA/µM. Moreover, the built-in sensor was utilized to measure PGB levels in both blood and Tablet with recoveries ranging from 96.67 to 109.19%. A detailed analysis of molecular structures, binding energies, and binding thermodynamic parameters of PGB-POPD configurations was performed using density functional theory methods. The calculated standard enthalpy change of binding indicates an exothermic process for all dimer and trimer configurations.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.